Lyra Therapeutics, Inc.
LYRA
$0.0873
$0.00080.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -60.51% | -49.66% | -41.89% | 5.33% | 4.96% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.38% | 18.90% | 7.61% | 11.14% | -29.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -58.95% | -48.11% | -41.28% | 5.48% | 3.96% |
|
|
|||||
| Total Current Assets | -58.95% | -48.11% | -41.28% | 5.48% | 3.96% |
| Net Property, Plant & Equipment | -39.54% | 228.24% | 1,069.44% | 1,190.39% | 689.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.38% | -77.50% | -63.40% | -48.95% | -46.44% |
| Total Assets | -53.47% | -34.68% | -24.74% | 50.77% | 29.67% |
|
|
|||||
| Total Accounts Payable | -62.34% | -54.65% | 18.70% | -28.02% | 19.69% |
| Total Accrued Expenses | -74.08% | -71.07% | -9.54% | 48.05% | -2.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.16% | 185.32% | 152.90% | 137.05% | 250.81% |
| Total Finance Division Other Current Liabilities | 80.69% | 216.45% | 163.26% | -12.65% | 49.38% |
| Total Other Current Liabilities | 80.69% | 216.45% | 163.26% | -12.65% | 49.38% |
| Total Current Liabilities | -35.55% | -22.26% | 36.60% | 32.29% | 35.43% |
|
|
|||||
| Total Current Liabilities | -35.55% | -22.26% | 36.60% | 32.29% | 35.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 41.09% | 540.90% | -- | 17,363.87% | 3,115.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.26% | -2.88% | -8.75% | -11.09% | -13.79% |
| Total Liabilities | 2.96% | 60.00% | 134.72% | 130.49% | 82.04% |
|
|
|||||
| Common Stock & APIC | 3.90% | 8.93% | 8.91% | 24.24% | 21.65% |
| Retained Earnings | -30.01% | -32.95% | -36.14% | -26.00% | -25.21% |
| Treasury Stock & Other | -- | 385.71% | 85.19% | 308.33% | 230.00% |
| Total Common Equity | -87.03% | -75.52% | -68.58% | 17.27% | 10.73% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -87.03% | -75.52% | -68.58% | 17.27% | 10.73% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -87.03% | -75.52% | -68.58% | 17.27% | 10.73% |
|
|
|||||